Wednesday Jul 16
Applied Clinical Trials
New Study Shows Beta-Amyloid Imaging is Associated with Altered...
Change in management was observed in both patients who met and did not meet the Appropriate Use Criteria , which were developed by the Society of Nuclear Medicine and Molecular Imaging and the Alzheimer's Association to provide guidance on which patients are most appropriate for imaging and how best to use the results.
2014 SNMMI Annual Meeting highlights research and looks to future
Top research from around the world and the latest advances in technology were brought together for the 2014 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in St. Louis, Mo., June 7-11.
Cath Lab Digest
Granulocyte Colony-Stimulating Factor (G-CSF) Therapy
June 12, 2014 - Researchers at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting revealed how a protein encourages the production of stem cells that regenerate damaged tissues of the heart following an acute myocardial infarction.
Washington University in St. Louis
Siegel receives Cassen Prize
Barry Siegel, MD, professor of radiology at Washington University School of Medicine in St. Louis, was awarded the Benedict Cassen Prize for Research in Nuclear Medicine during the annual meeting of the Society of Nuclear Medicine and Molecular Imaging.
FluoroPharma Announces That Data From Its Phase II Clinical Trial of...
FluoroPharma Medical, Inc. , a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography technology for the detection and assessment of disease before clinical manifestation, today announced that new Phase II trial data related to its CardioPET clinical trial was presented at the Society ... (more)